Enhanced muscle growth by plasmid-mediated delivery of myostatin propeptide

24Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Myostatin is a member of the transforming growth factor beta (TGF-β ) superfamily that functions as a negative regulator of skeletal muscle development and growth. Myostatin blockade therefore offers a strategy for promoting muscle growth in livestock production without resorting to genetic manipulation. In this report, we examined the effect of myostatin inhibition by plasmid-mediated delivery of a mutant myostatin propeptide (MProD76A), a natural inhibitor of myostatin, on the growth performance of mice. A significant increase in skeletal muscle mass was observed after a single intramuscular injection of naked plasmid DNA encoding MProD76A into mice. Enhanced muscle growth occurred because of myofiber hypertrophy, but no cardiac muscle hypertrophy and organomegaly was observed in the mice after myostatin inhibition by plasmid-mediated MProD76A delivery. These results demonstrate a promising approach to enhancing muscle growth that warrants further investigation in domestic animals. © 2010 Shengwei Hu et al.

Cite

CITATION STYLE

APA

Chen, C., Hu, S., Sheng, J., Sun, Y., Cao, X., & Qiao, J. (2010). Enhanced muscle growth by plasmid-mediated delivery of myostatin propeptide. Journal of Biomedicine and Biotechnology, 2010. https://doi.org/10.1155/2010/862591

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free